Clinical Trial Update: Evaluation of Somatostatin Receptor Imaging Using PET/MRI as a Novel Approach to Detecting Pathology in Pulmonary TB [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 evaluation of somatostatin receptor imaging using PET/MRI to detect pathology in pulmonary tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Tuberculosis | Phase 1 | Status: UNKNOWN